ClinicalTrials.gov record
Effect on Primary Dysmenorrhea
COMPLETED · NCT00909857
Trial record
NCT IDNCT00909857
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE3
Enrollment
507
Conditions
Primary Dysmenorrhea
Interventions
Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027), Ethinyl estradiol, Levonorgestrel (Miranova), Placebo Match to SH T00658ID, Placebo Match to SH D593B
Locations
Tucson, Arizona, United States, San Diego, California, United States, Hialeah, Florida, United States, Leesburg, Florida, United States, Sandy Springs, Georgia, United States, Idaho Falls, Idaho, United States, Winston-Salem, North Carolina, United States, Philadelphia, Pennsylvania, United States
Indexed topics
Last update
2015-08-06